SEC Contract Filing

Filing Date: 2020-07-06

Document Content:
<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>11
<FILENAME>a2019ex1039registratio.htm
<DESCRIPTION>EXHIBIT 10.39
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
 <!-- Document created using Wdesk 1 -->
 <!-- Copyright 2020 Workiva -->
 <title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3C2BA81A38B40C83B30E0BCACB1A6196"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Exhibit 10.39</font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:88px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:88px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">REGISTRATION RIGHTS AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">by and between</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;MIMEDX GROUP, INC.,</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">FALCON FUND 2 HOLDING COMPANY, L.P.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated as of July 2, 2020</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="sDBD3B04E659C8C5F13390BCACB3A8AE1"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">REGISTRATION RIGHTS AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This REGISTRATION RIGHTS AGREEMENT (this &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;) is entered into as of July 2, 2020, by and among MiMedx Group, Inc., a Florida corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Company</font><font style="font-family:inherit;font-size:12pt;">&#8221;), and Falcon Fund 2 Holding Company, L.P., a Delaware limited partnership (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchaser</font><font style="font-family:inherit;font-size:12pt;">&#8221;). Capitalized terms used but not defined elsewhere herein are defined in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit A</font><font style="font-family:inherit;font-size:12pt;">. The Purchaser and any other party that may become a party hereto pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 5.1</font><font style="font-family:inherit;font-size:12pt;">&#32;are referred to collectively as the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Investors</font><font style="font-family:inherit;font-size:12pt;">&#8221; and individually each as an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Investor</font><font style="font-family:inherit;font-size:12pt;">&#8221;.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, the Company and the Purchaser are parties to the Securities Purchase Agreement, dated as of June 30, 2020 (as it may be amended from time to time, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">SPA</font><font style="font-family:inherit;font-size:12pt;">&#8221;), pursuant to which the Company is selling to the Purchaser, and the Purchaser is purchasing from the Company, 90,000 shares of the Company&#8217;s Series&#160;B Convertible Preferred Stock, par value $0.001 per share (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Series B Preferred Stock</font><font style="font-family:inherit;font-size:12pt;">&#8221;)&#894; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, as a condition to the obligations of the Company and the Purchaser under the SPA, the Company and the Purchaser are entering into this Agreement for the purpose of granting certain registration rights to the Investors.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which